Pharmaceutical

Searchlight licenses Mithra’s menopause drug Donesta for Canadian market

Mithra Pharmaceuticals is in line to receive €17.05m ($18.8m) in licencing fees, and milestone-based payments.

Jul 31, 2023 - 20:00
Searchlight licenses Mithra’s menopause drug Donesta for Canadian market
Mithra Pharmaceuticals is in line to receive €17.05m ($18.8m) in licencing fees, and milestone-based payments.
Read the original article

Tags:

Previous Article

Non-profit receives FDA approval to supply cheaper OTC naloxone

Next Article

Santhera fully divests rare eye disease drug Raxone to Chiesi

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals

STAT+: With Fat Joe concerts and Super Bowl ads, a cadr...

May 25, 2023

Senate confirms Monica Bertagnolli as NIH director

Senate confirms Monica Bertagnolli as NIH director

Nov 7, 2023

STAT+: Annovis Bio delivers candor on its Parkinson’s study, even if it doesn’t inspire much confidence

STAT+: Annovis Bio delivers candor on its Parkinson’s s...

Feb 23, 2024